|Bid||0.0700 x 0|
|Ask||0.0750 x 0|
|Day's Range||0.0700 - 0.0700|
|52 Week Range||0.0450 - 0.7200|
|Beta (5Y Monthly)||3.41|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Scoping Test Work Underway Vancouver, British Columbia--(Newsfile Corp. - November 28, 2022) - Inomin Mines Inc. (TSXV: MINE), ("Inomin", "MINE" or the "Company") reports it has staked 1,516 hectares of mineral claims to enlarge the Company's Beaver-Lynx critical minerals project to 22,436 hectares. The new claims were acquired to cover prospective magnetic targets identified by airborne surveys.John Gomez, President of MINE comments, "Our significant discovery at Beaver confirmed that magnetic
Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, is pleased to announce that it intends to complete, subject to regulatory approval, a non-brokered private placement for gross proceeds of up to C$2,500,000 (the "Offering").
Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its Annual General Meeting ("AGM") of shareholders held virtually this morning.